Srs Capital Advisors, Inc. Biolife Solutions Inc Transaction History
Srs Capital Advisors, Inc.
- $1.95 Billion
- Q2 2025
A detailed history of Srs Capital Advisors, Inc. transactions in Biolife Solutions Inc stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 85 shares of BLFS stock, worth $2,260. This represents 0.0% of its overall portfolio holdings.
Number of Shares
85
Previous 50
70.0%
Holding current value
$2,260
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BLFS
# of Institutions
205Shares Held
50.4MCall Options Held
0Put Options Held
0-
Casdin Capital, LLC New York, NY7.71MShares$205 Million23.27% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$146 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.25MShares$113 Million0.06% of portfolio
-
Invesco Ltd. Atlanta, GA3.58MShares$95.2 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.9MShares$77 Million0.0% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $1.13B
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...